October 2023
-
10.16.2023 Covid-19 Diseases & Conditions Influenza mRNA Research Respiratory Syncytial Virus Vaccines Easing the Healthcare Burden of the Seasonal Triple-demic and Pfizer’s Unwavering Commitment to Public Health
March 2021
-
03.09.2021 Perspectives Albert Bourla Business Clinical Trials Covid-19 Diseases & Conditions Leadership mRNA Partnerships Patient Centricity Technology Vaccines Wellness Albert Bourla Reflects on the One Year Anniversary of the COVID-19 Pandemic
January 2021
-
01.22.2021 Perspectives Albert Bourla Business Covid-19 Diseases & Conditions mRNA Partnerships Patient Centricity Responsibility Vaccines Albert Bourla On Ensuring Equitable Access to COVID-19 Vaccines